Every 8-K that Diversified Healthcare Tr (DHC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow DHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DHC filings page.
Diversified Healthcare Trust reported second quarter 2026 results for the quarter ended June 30, 2026. Total revenues were $365,387 (dollars in thousands) versus $382,712 a year earlier. GAAP net loss narrowed to $37,419 (thousand), or $(0.16) per share. Normalized FFO rose to $38,896 (thousand), also $0.16 per share, while consolidated NOI increased to $84,443 (thousand) and Adjusted EBITDAre to $82,082 (thousand).
Performance improved notably in the senior housing operating portfolio: same property SHOP NOI grew 37.2% year over year to $51,975 (thousand), with margins at 17.3% and occupancy at 83.1%. The Medical Office and Life Science portfolio achieved same property occupancy of 95.8% and approximately 477,000 square feet of new and renewal leasing at rents 6.7% above prior levels.
Leverage metrics strengthened, with net debt to annualized Adjusted EBITDAre improving to 7.1x and interest coverage to 2.2x. As of June 30, 2026, DHC owned a $6,262,230 (thousand) healthcare real estate portfolio of 285 properties. The company declared a quarterly common distribution of $0.01 per share and reaffirmed full year 2026 guidance, including Total NOI of $307,000–$323,000 and Normalized FFO of $135,000–$150,000 (thousands) or $0.56–$0.62 per share.
Diversified Healthcare Trust held its annual shareholder meeting on June 10, 2026, where shareholders elected seven Trustees to one-year terms ending at the 2027 annual meeting. All nominees, including Christopher J. Bilotto, Alan Felder and Adam Portnoy, received more votes for than withheld.
Shareholders approved a non-binding advisory vote on the compensation of named executive officers, with 176,612,032 votes for and 8,812,215 against. They also ratified Deloitte & Touche LLP as independent auditors for the 2026 fiscal year, with 202,537,283 votes in favor and minimal opposition.
Diversified Healthcare Trust filed a current report to let investors know it has made a new investor presentation available. On June 1, 2026, the company posted this presentation on its website and attached it as Exhibit 99.1 to the report, where it is furnished for reference.
Diversified Healthcare Trust furnished a new investor presentation, dated May 5, 2026, and made it available on its website. The presentation is attached as Exhibit 99.1 to this Form 8-K. This is an informational update rather than a disclosure of specific new financial results or major transactions.
Diversified Healthcare Trust reported first quarter 2026 revenue of $366.5 million and a net loss of $43.3 million, or $0.18 per share. The loss narrowed compared to the prior year as operating metrics improved.
Same property senior housing operating (SHOP) performance strengthened, with same property SHOP NOI of $44.3 million, up 13.5% year over year, and NOI margins rising to 14.9%. Medical office and life science same property cash basis NOI grew 3.0% year over year, and occupancy reached 95.3%.
Normalized FFO was $33.1 million, or $0.14 per share, more than double the prior-year quarter, while Adjusted EBITDAre was $74.0 million. Leverage improved, with net debt to annualized Adjusted EBITDAre at 7.8x and Adjusted EBITDAre to interest expense at 2.0x. Liquidity totaled $271 million, including $121 million of cash and an undrawn $150 million secured revolver.
For full year 2026, DHC guides to total NOI of $297–313 million and Normalized FFO of $125–140 million ($0.52–0.58 per share), driven by expected 26–33% SHOP NOI growth and stable medical office and life science results. The company declared a quarterly common dividend of $0.01 per share.
Diversified Healthcare Trust filed a current report stating that it has posted a new investor presentation on its website. The presentation, dated February 24, 2026, is included as Exhibit 99.1 and is furnished as part of the disclosure to provide investors with updated information about the company.
Diversified Healthcare Trust reported a Q4 2025 net loss of $21.2 million, or $0.09 per share, but significantly stronger cash metrics, including normalized FFO of $21.8 million, or $0.09 per share, and Adjusted EBITDAre of $72.4 million. Same property senior housing operating portfolio (SHOP) cash NOI rose 27.6% year over year to $38.3 million, driven by 82.4% occupancy and a 5.8% increase in average monthly rates. The medical office and life science portfolio generated same property cash NOI of $24.1 million with 94.7% occupancy.
For full year 2025, DHC posted a net loss of $285.9 million, impacted by $165.7 million of impairments and high interest expense, while normalized FFO improved to $64.4 million. Management highlighted approximately $6.3 billion of real estate across 298 properties and noted it fully redeemed its zero‑coupon notes due 2026, reducing net debt to annualized Adjusted EBITDAre to 8.1x. The company issued 2026 guidance calling for NOI of $297–$313 million, Adjusted EBITDAre of $290–$305 million, and normalized FFO of $125–$140 million, with expected SHOP NOI growth of 26%–33%.
Diversified Healthcare Trust reported two key items. First, it incurred an incentive management fee of $17.9 million for the 2025 calendar year under its Business Management Agreement with The RMR Group LLC. This fee is payable in cash by January 30, 2026 and will be recorded as an expense in the company’s financial statements for the year ended December 31, 2025.
Second, on January 9, 2026, the company received a cash dividend of $27.2 million from AlerisLife Inc. in connection with AlerisLife’s sale of all assets and wind-down of its business. Diversified Healthcare Trust expects to receive an additional cash dividend of approximately $3.0 million to $7.0 million upon completion of that wind-down, though the amount or timing may change.
Diversified Healthcare Trust furnished an update on its business by announcing financial results for the quarter ended September 30, 2025. The company provided a summary press release and a detailed earnings presentation to accompany the results, making them available as Exhibits 99.1 and 99.2. This 8‑K is limited to distributing those materials and does not itself include the underlying figures.
Diversified Healthcare Trust filed a current report noting that it has made a new investor presentation available on its website. On October 8, 2025, the company posted this updated presentation, which is also attached to the report as Exhibit 99.1. The presentation is described as an investor communication and is furnished rather than filed, which typically means it is for informational purposes about the business rather than a formal change to financial statements or contracts.
DIVERSIFIED HEALTHCARE TRUST filed an 8-K reporting the execution of an indenture dated September 26, 2025 with U.S. Bank Trust Company, National Association as trustee. The indenture governs the company’s 7.250% Senior Secured Notes due 2030 and names certain subsidiaries as guarantors. The filing includes the form of the indenture and an Inline XBRL cover page.
The report is signed by Matthew C. Brown, Chief Financial Officer and Treasurer, indicating the company completed the documentation for the secured note issuance structure described in the filing.
Diversified Healthcare Trust reported that it has posted a new investor presentation to its website, providing updated information for shareholders and other stakeholders.
The company also announced that AlerisLife Inc. has sold the management agreements for 116 senior living communities owned by Diversified Healthcare Trust to seven different operators, as part of AlerisLife’s sale of all its assets and wind-down of its business. These changes in community operators are described in a press release dated September 3, 2025, which is included as an exhibit.
Diversified Healthcare Trust (DHC) filed a Form 8-K on 4 Aug 2025.
Under Item 2.02, the registrant disclosed that it has issued its Q2-25 financial results. The actual metrics are not contained in the body of the report; instead, investors are directed to two furnished exhibits:
- Exhibit 99.1: Summary press release dated 4 Aug 2025
- Exhibit 99.2: Detailed earnings presentation dated 4 Aug 2025
No additional transactions, guidance revisions, or balance-sheet details are provided in this filing.